Integration is an ecological engine where diverse forces unlock new pathways for development.
Leadership points the way forward, pushing boundaries and redefining the heights of the industry.
BIOCHINA 2026 (11th Edition) will take place at the Suzhou International Expo Center from March 12–14, bringing together four core components—Exhibition, Conference, Meetings, and Events—to create a high-level platform for collaboration across the entire biopharma industry chain. The event will bring together over 30,000 attendees from more than 40 countries and regions, featuring 850+ speakers, 250+ sub-forums, 3,000+ one-on-one meetings, and 400+ exhibitors! Morimatsu looks forward to welcoming you at Pharmaceutical Equipment & Laboratory Instruments Hall, Booth D3-006-009.
Highlight One:
Morimatsu and Bioengineering Make Their First Joint Appearance
This marks the first joint appearance since Bioengineering joined the Morimatsu Group. With more than 50 years of expertise in bioreactor technology, Bioengineering is widely recognized in the global biomanufacturing industry for its strong technical foundation. Through continuous innovation and a series of landmark projects, Bioengineering has consistently contributed to the advancement of biomanufacturing.
Technology Integration, Shared Value Creation. By closely integrating their strengths in technology R&D, global resources, and market channels, Morimatsu and Bioengineering are working together to provide global clients with more comprehensive and innovative one-stop solutions.
Highlight Two:
Cutting-Edge Technologies, Innovative Exhibits
The event centers on innovative drugs, with a focus on emerging areas such as XDC drugs, small-molecule drugs, polypeptide drugs, and antibody therapeutics. Drawing on years of technical expertise and industry experience, we will showcase a range of advanced processes and breakthrough solutions—supported by more comprehensive solutions, strong value propositions, and high-quality services.
1.Upstream Culture Solutions
2.Downstream Separation and Purification Solution
3.Single-Use Solutions
4.Pharmadule Morimatsu's Integrated Plant Solutions
Highlight Three:
Keynote Speech and Discussion
16:00-17:00, March 12
Hall D3 - Venue D306
Innovative Process Technology Development Forum
He Guolun, Deputy General Manager of Morimatsu Biotechnology
Bioreactor Scale-Up: Key Design Considerations from Pilot to Commercial Production
This presentation will explore the core principles, technical challenges, and practical approaches of bioreactor scale-up, sharing relevant solutions and real-world application cases.
At the forefront of the rapidly evolving biotech industry, we warmly invite you to join us in advancing biopharmaceutical innovation and shaping the next golden era of China’s biopharma sector.
Spring has returned to Jiangnan, and in Suzhou we gather once more.
We warmly await you to join this joyful celebration.
About Morimatsu LifeSciences
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.
Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.
Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.
As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
